Notice of AGM & availability of Annual Report

Futura Medical (AIM: FUM), the consumer healthcare Group behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, today announces its Annual General Meeting ("AGM") will be held at 10:00am on Monday, 29 June 2026 at the offices of Panmure Liberum, Ropemaker Place, 25 Ropemaker Street, London EC2Y 9LY.

If you wish to attend the meeting in person, please register your interest at investor.relations@futuramedical.com.

Shareholders are asked to cast their vote as follows: (1) casting your proxy vote online via the Investor Centre app or by accessing the web browser at https://uk.investorcentre.mpms.mufg.com/ and following the instructions; or (2) in the case of CREST members, by utilising the CREST electronic proxy appointment service; or (3) if you are an institutional investor you may also be able to appoint a proxy electronically via the Proxymity platform; or (4) requesting a hard copy form of proxy directly from the Registrars, MUFG Corporate Markets. For further information, please refer to the notes to the Notice of Annual General Meeting. If you choose to attend the Annual General Meeting in person instead of appointing the Chairman of the meeting as proxy, you will still be able to vote in person at the Annual General Meeting.

If you are not attending the Annual General Meeting in person, your proxy vote will need to be logged by 10:00am on Thursday, 25 June 2026, as no online voting will take place in-real time during the meeting itself.

Annual Report

Futura's annual report and accounts for the year ended 31 December 2025 (the "Annual Report") is available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is now available on the Company's website www.futuramedical.com, along with the Notice of AGM.